Literature DB >> 17320110

Nuclear transport of Ras-associated tumor suppressor proteins: different transport receptor binding specificities for arginine-rich nuclear targeting signals.

Gita Kumari1, Prabhat K Singhal, M R K Subba Rao, S Mahalingam.   

Abstract

Ras proteins regulate a wide range of biological processes by interacting with a variety of effector proteins. In addition to the known role in tumorigensis, the activated form of Ras exhibits growth-inhibitory effects by unknown mechanisms. Several Ras effector proteins identified as mediators of apoptosis and cell-cycle arrest also exhibit properties normally associated with tumor suppressor proteins. Here, we show that Ras effector RASSF5/NORE-1 binds strongly to K-Ras but weakly to both N-Ras and H-Ras. RASSF5 was found to localize both in the nucleus and the nucleolus in contrast to other Ras effector proteins, RASSF1C and RASSF2, which are localized in the nucleus and excluded from nucleolus. A 50 amino acid residue transferable arginine-rich nucleolar localization signal (NoLS) identified in RASSF5 is capable of interacting with importin-beta and transporting the cargo into the nucleolus. Surprisingly, similar arginine-rich signals identified in RASSF1C and RASSF2 interact with importin-alpha and transport the heterologous cytoplasmic proteins to the nucleus. Interestingly, mutation of arginine residues within these nuclear targeting signals prevented interaction of Ras effector proteins with respective transport receptors and abolished their nuclear translocation. These results provide evidence for the first time that arginine-rich signals are able to recognize different nuclear import receptors and transport the RASSF proteins into distinct sub-cellular compartments. In addition, our data suggest that the nuclear localization of RASSF5 is critical for its cell growth control activity. Together, these data suggest that the transport of Ras effector superfamily proteins into the nucleus/nucleolus may play a vital role in modulating Ras-mediated cell proliferation during tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17320110     DOI: 10.1016/j.jmb.2007.01.026

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  15 in total

1.  The Ras effector RASSF2 controls the PAR-4 tumor suppressor.

Authors:  Howard Donninger; Luke Hesson; Michele Vos; Kristin Beebe; Laura Gordon; David Sidransky; Jun Wei Liu; Thomas Schlegel; Shannon Payne; Arndt Hartmann; Farida Latif; Geoffrey J Clark
Journal:  Mol Cell Biol       Date:  2010-04-05       Impact factor: 4.272

2.  ORF73 LANA homologs of RRV and MneRV2 contain an extended RGG/RG-rich nuclear and nucleolar localization signal that interacts directly with importin β1 for non-classical nuclear import.

Authors:  Kellie Howard; Lidia Cherezova; Laura K DeMaster; Timothy M Rose
Journal:  Virology       Date:  2017-08-29       Impact factor: 3.616

3.  Ectopic expression of RASSF2 and its prognostic role for gastric adenocarcinoma patients.

Authors:  Deng Luo; Ting Ye; Tian-Qian Li; Peng Tang; Sha-Dong Min; Gong-Fang Zhao; Hua Huang; Jiang Chang; Yan Wang; Lin Lv; Ming-Liang Lu; Meng-Yao Zheng
Journal:  Exp Ther Med       Date:  2011-12-28       Impact factor: 2.447

Review 4.  Ras signaling through RASSF proteins.

Authors:  Howard Donninger; M Lee Schmidt; Jessica Mezzanotte; Thibaut Barnoud; Geoffrey J Clark
Journal:  Semin Cell Dev Biol       Date:  2016-06-08       Impact factor: 7.727

5.  Ras Regulates Rb via NORE1A.

Authors:  Thibaut Barnoud; Howard Donninger; Geoffrey J Clark
Journal:  J Biol Chem       Date:  2015-12-16       Impact factor: 5.157

6.  Nonstructural protein 5B promotes degradation of the NORE1A tumor suppressor to facilitate hepatitis C virus replication.

Authors:  Payal Arora; Amartya Basu; M Lee Schmidt; Geoffrey J Clark; Howard Donninger; Daniel B Nichols; Diego F Calvisi; Neerja Kaushik-Basu
Journal:  Hepatology       Date:  2017-03-30       Impact factor: 17.425

7.  RASSF2 associates with and stabilizes the proapoptotic kinase MST2.

Authors:  W N Cooper; L B Hesson; D Matallanas; A Dallol; A von Kriegsheim; R Ward; W Kolch; F Latif
Journal:  Oncogene       Date:  2009-06-15       Impact factor: 9.867

Review 8.  Ras proteins: paradigms for compartmentalised and isoform-specific signalling.

Authors:  J Omerovic; A J Laude; I A Prior
Journal:  Cell Mol Life Sci       Date:  2007-10       Impact factor: 9.261

9.  Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer.

Authors:  W N Cooper; R E Dickinson; A Dallol; E V Grigorieva; T V Pavlova; L B Hesson; I Bieche; M Broggini; E R Maher; E R Zabarovsky; G J Clark; F Latif
Journal:  Oncogene       Date:  2007-09-24       Impact factor: 9.867

10.  The E3 ubiquitin ligase Itch regulates tumor suppressor protein RASSF5/NORE1 stability in an acetylation-dependent manner.

Authors:  R Suryaraja; M Anitha; K Anbarasu; G Kumari; S Mahalingam
Journal:  Cell Death Dis       Date:  2013-03-28       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.